Arterial Spin-Labeling Perfusion Lightbulb Sign: An Imaging Biomarker of Pediatric Posterior Fossa Hemangioblastoma

References

1. 1.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
2. 2.↵
   1. Wang H,
   2. Zhang L,
   3. Wang H, et al

   . Spinal hemangioblastoma: surgical procedures, outcomes and review of the literature. Acta Neurol Belg 2021;121:973–81 doi:10.1007/s13760-020-01420-4 pmid:32638270

   CrossRefPubMed
3. 3.↵
   1. Mills SA,
   2. Oh MC,
   3. Rutkowski MJ, et al

   . Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease. Neuro Oncol 2012;14:1097–104 doi:10.1093/neuonc/nos133 pmid:22723428

   CrossRefPubMed
4. 4.↵
   1. Neumann HP,
   2. Eggert HR,
   3. Weigel K, et al

   . Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 1989;70:24–30 doi:10.3171/jns.1989.70.1.0024 pmid:2909683

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Binderup MLM,
   2. Smerdel M,
   3. Borgwadt L, et al

   . von Hippel-Lindau disease: updated guideline for diagnosis and surveillance. Eur J Med Genet 2022;65:104538 doi:10.1016/j.ejmg.2022.104538 pmid:35709961

   CrossRefPubMed
6. 6.↵
   1. Wang Q,
   2. Meng S,
   3. Cheng J, et al

   . Central nervous system hemangioblastomas: an age-stratified analysis. Clin Neurol Neurosurg 2020;199:106281 doi:10.1016/j.clineuro.2020.106281 pmid:33091656

   CrossRefPubMed
7. 7.↵
   1. Cha J,
   2. Kim ST,
   3. Nam DH, et al

   . Differentiation of hemangioblastoma from metastatic brain tumor using dynamic contrast-enhanced MR imaging. Clin Neuroradiol 2016;27:329–34 doi:10.1007/s00062-016-0508-1 pmid:26952018

   CrossRefPubMed
8. 8.↵
   1. Kim EH,
   2. Moon JH,
   3. Kang S-G, et al

   . Diagnostic challenges of posterior fossa hemangioblastomas: refining current radiological classification scheme. Sci Rep 2020;10:6267 doi:10.1038/s41598-020-63207-0 pmid:32286416

   CrossRefPubMed
9. 9.↵
   1. She D,
   2. Yang X,
   3. Xing Z, et al

   . Differentiating hemangioblastomas from brain metastases using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2016;37:1844–50 doi:10.3174/ajnr.A4809 pmid:27173365

   Abstract/FREE Full Text
10. 10.↵
    1. She DJ,
    2. Xing Z,
    3. Zeng Z, et al

    . Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy. Neuroradiology 2015;57:275–81 doi:10.1007/s00234-014-1475-3 pmid:25487356

    CrossRefPubMed
11. 11.↵
    1. Kurokawa R,
    2. Kurokawa M,
    3. Baba A, et al

    . Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI. Medicine (Baltimore) 2022;101:e31708 doi:10.1097/MD.0000000000031708 pmid:36343086

    CrossRefPubMed
12. 12.↵
    1. Yamashita K,
    2. Yoshiura T,
    3. Hiwatashi A, et al

    . Arterial spin labeling of hemangioblastoma: differentiation from metastatic brain tumors based on quantitative blood flow measurement. Neuroradiology 2012;54:809–13 doi:10.1007/s00234-011-0977-5 pmid:22068625

    CrossRefPubMed
13. 13.↵
    1. Kang KM,
    2. Sohn CH,
    3. You SH, et al

    . Added value of arterial spin-labeling MR imaging for the differentiation of cerebellar hemangioblastoma from metastasis. AJNR Am J Neuroradiol 2017;38:2052–58 doi:10.3174/ajnr.A5363 pmid:28912280

    Abstract/FREE Full Text
14. 14.↵
    1. Noguchi T,
    2. Yoshiura T,
    3. Hiwatashi A, et al

    . Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 2008;29:688–93 doi:10.3174/ajnr.A0903 pmid:18184842

    Abstract/FREE Full Text
15. 15.↵
    1. Palavani LB,
    2. Andreão FF,
    3. de Abreu LV, et al

    . Assessing the efficacy and safety of hemangioblastoma embolization: a comprehensive systematic review and meta-analysis. J Clin Neurosci 2023;117:104–13 doi:10.1016/j.jocn.2023.09.021 pmid:37788533

    CrossRefPubMed
16. 16.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M, et al

    . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;3709596:1453–57
17. 17.↵
    1. Jagannathan J,
    2. Lonser RR,
    3. Smith R, et al

    . Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2008;108:210–22 doi:10.3171/JNS/2008/108/2/0210 pmid:18240914

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Inoue M,
    2. Oya S,
    3. Yamaga T, et al

    . Pearls & oy-sters: cognitive and affective dysfunction caused by a small cerebellar hemangioblastoma. Neurology 2023;101:e1272–75 doi:10.1212/WNL.0000000000207509 pmid:37407260

    Abstract/FREE Full Text
19. 19.↵
    1. Xia H,
    2. Li J,
    3. Xia Y, et al

    . Sporadic solid/cystic hemangioblastomas in the cerebellum: retrospective study of more than ten years of experience in a single center. World Neurosurg 2020;144:e908–15 doi:10.1016/j.wneu.2020.09.104 pmid:32980566

    CrossRefPubMed
20. 20.↵
    1. Nie Q,
    2. Guo P,
    3. Shen L, et al

    . Early-stage hemangioblastoma presenting as a small lesion with significant edema in the cerebellum. J Craniofac Surg 2015;26:e119–21 doi:10.1097/SCS.0000000000001344 pmid:25699527

    CrossRefPubMed
21. 21.↵
    1. Laviv Y,
    2. Saraf D,
    3. Oxman L, et al

    . Supratentorial hemangioblastoma: correlation between phenotype, gender and vascular territory affected. Neurosurg Rev 2023;46:281 doi:10.1007/s10143-023-02194-y pmid:37875641

    CrossRefPubMed
22. 22.↵
    1. Klingler J-H,
    2. Gläsker S,
    3. Bausch B, et al

    . Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment. Childs Nerv Syst 2020;36:2537–52 doi:10.1007/s00381-020-04712-5 pmid:32507909

    CrossRefPubMed
23. 23.↵
    1. Sabin ND,
    2. Hwang SN,
    3. Klimo P, et al

    . Anatomic neuroimaging characteristics of posterior fossa type A ependymoma subgroups. AJNR Am J Neuroradiol 2021;42:2245–50 doi:10.3174/ajnr.A7322 pmid:34674998

    Abstract/FREE Full Text
24. 24.↵
    1. Luo Y,
    2. Zhang S,
    3. Tan W, et al

    . The diagnostic efficiency of quantitative diffusion weighted imaging in differentiating medulloblastoma from posterior fossa tumors: a systematic review and meta-analysis. Diagnostics (Basel) 2022;12:1211 doi:10.3390/diagnostics12112796

    CrossRefPubMed
25. 25.↵
    1. Bing F,
    2. Kremer S,
    3. Lamalle L, et al

    . Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings. Article in French. J Neuroradiol 2009;362:82–87 doi:10.1016/j.neurad.2008.09.002

    CrossRef
26. 26.↵
    1. Gaudino S,
    2. Martucci M,
    3. Botto A, et al

    . Brain DSC MR perfusion in children: a clinical feasibility study using different technical standards of contrast administration. AJNR Am J Neuroradiol 2019;40:359–65 doi:10.3174/ajnr.A5954 pmid:30655255

    Abstract/FREE Full Text
27. 27.↵
    1. Narayanan S,
    2. Schmithorst V,
    3. Panigrahy A

    . Arterial spin labeling in pediatric neuroimaging. Semin Pediatr Neurol 2020;33:100799 doi:10.1016/j.spen.2020.100799 pmid:32331614

    CrossRefPubMed
28. 28.↵
    1. Taso M,
    2. Alsop DC

    . Arterial spin labeling perfusion imaging. Magn Reson Imaging Clin N Am 2024;32:63–72 doi:10.1016/j.mric.2023.08.005 pmid:38007283

    CrossRefPubMed
29. 29.↵
    1. Iutaka T,
    2. de Freitas MB,
    3. Omar SS, et al

    . Arterial spin labeling: techniques, clinical applications, and interpretation. Radiographics 2023;43:e220088 doi:10.1148/rg.220088 pmid:36367822

    CrossRefPubMed
30. 30.↵
    1. Kishi S,
    2. Maeda M,
    3. Kogue R, et al

    . Hemangioblastoma of the cerebellopontine angle evaluated with pseudocontinuous arterial spin labeling. Magn Reson Med Sci 2021;20:18–19 doi:10.2463/mrms.ici.2020-0011 pmid:32132312

    CrossRefPubMed